Trademark applications and grants for Csl Behring L L C. Csl Behring L L C has 200 trademark applications. The latest application filed is for "DRIVEN BY OUR PROMISE"
Patent Application | Date |
---|---|
DONOR T-CELLS WITH KILL SWITCH 20210340563 - 17/353572 Symonds; Geoffrey Phillip ;   et al. | 2021-11-04 |
NANOCAPSULES FOR THE DELIVERY OF CELL MODULATING AGENTS 20210322331 - 17/353440 Yan; Ming ;   et al. | 2021-10-21 |
HAEMATOPOIETIC STEM CELL-GENE THERAPY FOR WISKOTT-ALDRICH SYNDROME 20210316013 - 17/353586 Vonarburg; Cedric Pierre ;   et al. | 2021-10-14 |
METHODS FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATION 20210008182 - 16/768281 UKNIS; Marc ;   et al. | 2021-01-14 |
METHODS OF TREATMENT USING ALPHA-1-ANTITRYPSIN COMPOSITIONS 20200078451 - 16/411627 KEE; Scott M. ;   et al. | 2020-03-12 |
NCAGE Code | 07PZ8 | CSL BEHRING L.L.C. |
CAGE Code | 07PZ8 | CSL BEHRING L.L.C. |
S.A.M. Registration | 07PZ8 [931896963] | CSL BEHRING L.L.C. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.